Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CT Caldera TherapeuticsCompany profile Develops bispecific antibody CLD-423 for inflammatory bowel disease Develops bispecific antibody CLD-423 for inflammatory bowel disease | $37.5M | Series A1Series A | Biotech | United States | Investors | |
| RL |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
Develops AI operating system for oncology workflows
Develops AI operating system for oncology workflows
| $11.1M |
| Series A |
| Biotech, AI |
| United States |
| Investors |
| AB Provider of human induced pluripotent stem cell (iPSC) technologies | $2.8M | Undisclosed | Biotech | United Kingdom | Investors |
| VO Vivere OncotherapiesCompany profile Develops cancer therapies that activate the immune system to detect and destroy cancer cells in t... Develops cancer therapies that activate the immune system to detect and destroy cancer cells in t... | $10M | Series A | Biotech | United States | Investors |
| N NucleraCompany profile Provides rapid access to functional proteins through benchtop eProtein Discovery System Provides rapid access to functional proteins through benchtop eProtein Discovery System | $12M | Series C+ | Biotech | United Kingdom | Investors |
| S Provides enterprise informatics platform for laboratories | Undisclosed | Undisclosed | Biotech, Enterprise software | United States | Investors |
| CB AI platform for accelerated drug discovery and development | $25M | Series A | Biotech, AI | United States | Investors |
| P Develops AI-driven drug discovery for proximity therapeutics | $80M | Undisclosed | Biotech | United States | Investors |
| AB Avenue BiosciencesCompany profile Develops high-throughput protein engineering technology for biologics manufacturing Develops high-throughput protein engineering technology for biologics manufacturing | $5.7M | Seed+Seed | Biotech | United States | Investors |
| F FluoSpheraCompany profile Develops human-based preclinical platform for drug safety and efficacy testing Develops human-based preclinical platform for drug safety and efficacy testing | €1.2M | Undisclosed | Biotech | Switzerland | Investors |